Bank of New York Mellon
IHE icon

Bank of New York Mellon’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bank of New York Mellon’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,278
Closed -$215K – 4318
2017
Q1 		$215K Buy
+4,278
New +$212K ﹤0.01% 3856
2016
Q4 		– Sell
-13,380
Closed -$666K – 4288
2016
Q3 		$666K Buy
13,380
+855
+7% +$43.4K ﹤0.01% 3394
2016
Q2 		$603K Sell
12,525
-102
-0.8% -$4.85K ﹤0.01% 3432
2016
Q1 		$577K Sell
12,627
-546
-4% -$25.5K ﹤0.01% 3369
2015
Q4 		$710K Buy
13,173
+393
+3% +$20.7K ﹤0.01% 3368
2015
Q3 		$630K Buy
+12,780
New +$733K ﹤0.01% 3471

Other funds holding IHE

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PAG
Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $2.06B AUM 24.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RTS
Round Table Services Westfield, New Jersey $508M AUM 16.36% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bank of New York Mellon's IHE Position: Q2 2017 in Review

Bank of New York Mellon sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2017, closing a stake of 4,278 shares — an estimated $215K sold.

Bank of New York Mellon first reported a position in IHE in Q3 2015 and held it in 6 quarters. The position peaked at $710K in Q4 2015. 95 funds tracked by Wall St. Rank hold IHE as of Q2 2017.

  • Bank of New York Mellon reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 4,278 iShares US Pharmaceuticals ETF shares in Q2 2017, an estimated $215K.
  • Bank of New York Mellon first reported a position in iShares US Pharmaceuticals ETF in Q3 2015 and held it in 6 quarters.
  • Bank of New York Mellon's iShares US Pharmaceuticals ETF position peaked at $710K in Q4 2015.
  • 95 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2017.

Based on Bank of New York Mellon's 13F filing for Q2 2017, filed 3 Aug 2017.